ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Aridis Pharmaceuticals, Inc. Common Stock (ARDS)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aridis Pharmaceuticals, Inc. Common Stock
Symbol: ARDS
Shares outstanding: 44,586,623 shares
Disclosed Ownership: 5,096,251 shares
Ownership: 11%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 21:38:08 UTC
Date of event: 30 Jun 2025
Previous filing: 15 May 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	11%	5,096,251	0	5,096,251	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	11%	5,096,251	0	5,096,251	/s/ Steven Boyd	Steven Boyd